Uric Acid Control (bf 12/2024)

This product contains Terminalia bellerica extract intended to reduce uric acid levels and support a healthy inflammatory response.

• The description claims a 9.8% average decrease in uric acid levels after 4 weeks.
• The description claims a 28.4% reduction in uric acid levels at the end of a 24-week trial.
• The description claims that the product may help support a healthy response to inflammatory factors and has antioxidant properties.
• The description claims that no adverse side effects were reported during the trial.